CAROL GREER: Open Payments
NPI 1497734230 · TAYLOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 12 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $88 · 2025 $1,268
Food & beverage: $1,268
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $295 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $196 |
| Inspire Medical Systems, Inc. | 1 | $160 |
| Neurelis, Inc. | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| JAZZ PHARMACEUTICALS INC. | 1 | $122 |
| Lundbeck LLC | 1 | $110 |
| Janssen Biotech, Inc. | 1 | $95 |
| Janssen Scientific Affairs, LLC | 1 | $45 |
Products named: TEPEZZA, XIFAXAN, INSPIRE, TREMFYA, VALTOCO, AIRSUPRA, EPIDIOLEX, REXULTI.
Industry payments across MI — which companies pay providers there.
